The US FDA has approved olaparib for the maintenance treatment of some adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) metastatic pancreatic adenocarcinoma.
Patterns of genetic alterations could guide management.
Overall cancer mortality and mortality for liver, esophageal, pancreatic cancer up with severe psoriasis.
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Evidence reviewed for radiation therapy in adjuvant, neoadjuvant, definitive, and palliative settings.